Bluefish plans rapid European expansion with SAP business solution

The Swedish generic pharmaceutical company Bluefish Pharmaceuticals has signed a contract with Swedish SAP partner Implema for the implementation of the business system SAP. Bluefish, whose goal is to become a pan-European pharmaceutical company, chose SAP to be able to expand their business quickly throughout Europe. SAP will initially be implemented at Bluefish’s companies in Sweden, Germany, Finland, the Netherlands, Italy and India. SAP will be rolled out in parallel across the six countries.

– The implementation of SAP as a platform for our business processes is an important step in preparing our organization for the expansion of our business model within the rest of Europe, says Karl Karlsson Bluefish Pharmaceuticals President and CEO. We chose SAP as they have very good inter-company functionality for business groups operating in multiple markets. One common corporate business platform will allow us – with no limitations - to expand our product portfolio, launch new products and enter new markets.

Founded in 2005, Bluefish Pharmaceuticals aims to build a pan-European pharmaceuticals company. Bluefish's medicines are mainly manufactured with subcontractors in India where Bluefish also has a wholly owned subsidiary.

Bluefish forecasts great sales potential and growth throughout Europe for all 27 products in the portfolio. Bluefish's products are already available in Sweden, Germany, Denmark, the Netherlands, Norway and Finland. More European markets will be entered during 2009.

Initially SAP will be implemented at the company’s operations in Sweden, Germany, Finland, the Netherlands, Italy and India. The Swedish SAP partner, Implema is responsible for the project.

– We chose Implema as they have previous experience of the pharmaceutical industry and several reference customers with business processes similar to ours. We also like the fact that Implema is managed by the founders of the company, says Karl Karlsson.